Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TEL vs GSK✓SelectedUSD · GSKTEL vs GSK performance historyLatest closeAs of-0.68%11/13
Stock and ETF performance explorer

TEL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+285.8%
GSK return
+105.0%
Excess return
+180.8%
Maximum drawdown
-47.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.7%+0.5%-1.2%-0.9%
7D+4.5%+1.1%+3.4%+4.1%
30D+2.9%+6.3%-3.4%+0.6%
3M+1.1%+1.8%-0.7%+0.1%
6M+5.0%+1.7%+3.3%+3.6%
YTD-3.9%+6.5%-10.4%-7.2%
1Y-7.4%+9.5%-16.9%-11.5%
3Y+81.0%+65.3%+15.7%+42.3%
5Y+42.3%+43.7%-1.4%+16.9%
All+285.8%+105.0%+180.8%+174.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling